Related Experiment Video
Updated: Jan 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Clinical Characteristics and Management of Infective Native Arterial Aneurysms Associated with BCG Therapy for
Giulia Colonna1, David Liesker2, Wouthuyzen-Bakker M3
1Departments of Surgery (Division of Vascular Surgery), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Vascular and Endovascularvascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, "Sapienza" University of Rome, Rome, Italy.
Background:
Intravesical Bacille Calmette-Guérin (BCG) immunotherapy is a well-established treatment for bladder cancer. Although generally safe, rare but severe complications such as Mycobacterium bovis-induced infected native arterial aneurysms (INAAs) can occur. These complications present diagnostic and therapeutic challenges due to their delayed onset and nonspecific symptoms. This systematic review aims to evaluate the causes, clinical presentation, diagnostic strategies, and management of BCG-induced INAA and to report an additional clinical case from the present institution.
Methods:
A systematic review of the literature was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines. PubMed was searched for English-language case reports published up to March 2025, describing arterial aneurysms as complications of intravesical BCG immunotherapy. Inclusion criteria required documented BCG treatment, no prior aneurysm, and microbiological or clinical confirmation of INAA.
Results:
A total of 56 case reports involving 58 patients were included. Most patients were male (98%) with a mean age of 72.2 years (standard deviation (SD) ± 7.7). Abdominal aortic aneurysms were most frequent (70.4%), followed by thoracic and peripheral aneurysms. The median interval between BCG instillations and INAA diagnosis was 12 months (interquartile range (IQR): 7.5-27.5). Treatment included open surgical repair (69%), endovascular repair (24.1%), and conservative management (3.5%). The median duration of antimicrobial treatment was 9 months (IQR 8-12). Overall mortality was 15.7%, and the complication rate was 33.3%.
Conclusion:
BCG-induced INAA is a rare but life-threatening complication, and early recognition is critical. Optimal management involves targeted antimicrobial therapy and timely surgical intervention, either open or endovascular, based on the patient's condition and aneurysm characteristics.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management

